J Gynecol Oncol.
2019 Nov;30(6):e116. 10.3802/jgo.2019.30.e116.
Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
- Affiliations
-
- 1Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Fudan University Zhongshan Hospital, Shanghai, China. zang.rongyu@zs-hospital.sh.cn
- 2Department of Gynecologic Oncology, University Cancer Hospital of Chinese Science Academy, Hangzhou, China.
- KMID: 2458912
- DOI: http://doi.org/10.3802/jgo.2019.30.e116
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
- Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
- Current status of application of the secondary cytoreductive surgery for patients with epithelial ovarian carcinomas
- An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer
- Chemotherapy for ovarian cancer
